Sanofi Consumer Healthcare Q3 FY25: Net profit up 40% at Rs 629M

Revenue growth above 20%Profit growth above 25%Exceptional itemResults View source PDF Explain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.6%Reaction day

₹4641.00

prior close

₹4760.90

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%+7.7% vs market

Pharmaceuticals peers, median of 157sector-0.1%+7.8% vs sector

On the reaction day the stock moved 7.7 pts more than Nifty Microcap 250 and 7.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.1

10m

+5.7

15m

+4.4

30m

+4.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.6-0.1+7.7-0.1+7.8

Next day

+3.9-0.2+4.1-0.5+4.3

+2.5+0.4+2.0-0.4+2.9

+1.2-0.4+1.6-1.1+2.3

+1.0-0.6+1.6-1.4+2.4

+3.1-0.9+4.0-1.6+4.7

+3.4-3.0+6.4-3.3+6.8

15d

+0.9-3.9+4.8-3.4+4.4

-1.5-4.8+3.3-4.3+2.8

-8.1-7.8-0.3-6.6-1.5

-7.6-7.2-0.3-8.8+1.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY25 revenue rose 46% YoY to Rs 2,339M, driven by 20% domestic growth and over ten times jump in exports on a low base. Net profit rose 40% to Rs 629M with EPS at Rs 27.29. Nine month revenue grew 13% to Rs 6,274M and profit rose 27% to Rs 1,736M. All recalled products relaunched.

Likely market impact

Strong quarter with revenue and profit growth well above last year, aided by export recovery and product relaunches.